LexPharma
@LexPharma
Followers
655
Following
44
Media
331
Statuses
360
Precision science. Pioneering medicine. Patient driven.
The Woodlands, TX
Joined July 2016
Lexicon’s Q3 financial results are now available. Dive into our latest business updates by checking out our press release: https://t.co/aNBfLSbOV5
1
0
2
To wrap up the amazing 2025 HCMA Patient Meeting weekend, the Lexicon team joined in on the BigHearted 5K run/walk. We’re proud to work on behalf of this community and together, we can make a difference for patients!
4
1
8
This week, the Lexicon team shared new data from our investigational DPNP program at the 19th Annual Pain Therapeutics Summit. Learn more: https://t.co/KmJtKVhoH5
0
2
7
Lexicon is proud to have convened a roundtable to address public policy gaps for people with chronic pain. Read more about the discussion here: https://t.co/pOK38tfv7B
2
3
11
Chronic pain affects millions, yet current federal and state policies to expand access to non-opioid treatments often leave these patients behind. It’s time to ensure chronic pain is included in the conversation. Tomorrow, we're meeting in Washington DC to move this work forward.
2
2
9
Chronic pain impacts patients and caregivers every day — yet too often, their voices are left out of health policy discussions. We’re working to change that. Next week in Washington, DC, we’re advancing the conversation to better support people living with chronic pain.
1
2
8
Join us as we celebrate Lexicon’s 30th anniversary! For three decades we’ve been committed to exploring promising science to positively improve the lives of patients in need. Learn more about our journey in CEO Mike Exton's article:
linkedin.com
Today, we are celebrating the 30th anniversary of Lexicon! 🎉 I'm reflecting on our three-decade journey from early discovery to developing novel therapeutics, and how each decade had a distinct...
2
1
8
On #WorldHeartDay, Lexicon is raising awareness of heart health and ensuring those with heart conditions, like #HCM and #HF, get the support and care they deserve. Join us in advocating for healthy hearts!
2
2
5
Earlier today, Dr. Pop-Busui presented secondary data from our Phase 2b PROGRESS study in patients with diabetic peripheral neuropathic pain (DPNP) at the @EASDnews 2025 Conference. Learn more: https://t.co/rZnW0MZk2j
3
4
13
DPNP brings relentless pain for over 60% of patients, disrupting daily life. Current treatments often fall short in providing relief. This #PainAwarenessMonth, we're highlighting the urgent need for new treatment options to better support those affected.
0
1
12
Over the next few months, the Lexicon team will present data on our investigational non-opioid therapy for diabetic peripheral neuropathic pain at @Neurodiab_eu Annual Meeting, @EASDnews 2025, and the 19th Annual Pain Therapeutics Summit. Learn more here: https://t.co/w3oo6K3gr6
0
1
12
Alina Cocuzza, PharmD, and Pamela Price, PharmD, are at the 2025 @PAINWeek Conference this week representing Lexicon and showing our commitment to helping ease pain for patients, like those with diabetic peripheral neuropathic pain. #PAINWeek2025
0
2
10
We're presenting at the @HCWCO 27th Annual Global Investment Conference next week. Find presentation details on our Investor Relations website: https://t.co/krelLAWeig
1
0
10
Lexicon is attending @IASPpain’s congress this weekend, presenting new preclinical data on our AAK1 inhibitor impacting neuropathic pain in CIPN & MS models. Learn more here: https://t.co/ybb7kLug1Z
#NeuPSIG2025
0
2
11
We were in Boston today for @Citi’s 2025 Biopharma Back to School Conference, where we participated in a fireside chat to share exciting updates on our recent progress. You can view the webcast on our Events page here: https://t.co/krelLAWM7O
2
1
8
This weekend, Lexicon presented data in an oral presentation at the @escardio 2025 conference on our SGLT 1/2 inhibitor for those with heart failure. Read more in our press release: https://t.co/M8YOST0MAR
1
2
9
Hypertrophic Cardiomyopathy (HCM) affects an estimated 1.1 million Americans. Despite treatment progress, there’s still a need for better management, and we’re committed to developing a potential therapy to improve patient care. #LearnwithLexicon
0
2
10
We had an amazing time at @TCOYD’s ONE 2025 Conference! Each year we leave more inspired than ever by this vibrant community.
1
1
7
Today, Lexicon announced its Q2 2025 financial results. Find our business updates here: https://t.co/Kb6BX6XeHO
3
3
11
We had an amazing weekend at the @ASPCardio conference! We were proud to sponsor this event and engage with leaders at the forefront of advancing care for those with cardiovascular disease. #ASPC2025
1
1
12